Literature DB >> 4259250

Plasma dehydroepiandrosterone sulphate levels in patients with benign and malignant breast disease.

B Brownsey, E H Cameron, K Griffiths, E N Gleave, A P Forrest, H Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4259250     DOI： 10.1016/0014-2964(72)90094-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.

Authors:  G B Gordon; D E Bush; H F Weisman
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

Review 2.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Mechanisms of chemoprevention by dietary dehydroisoandrosterone. Inhibition of lymphopoiesis.

Authors:  G Risdon; J Cope; M Bennett
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

4.  Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs.

Authors:  J L Glaser; J L Brind; J H Vogelman; M J Eisner; M C Dillbeck; R K Wallace; D Chopra; N Orentreich
Journal:  J Behav Med       Date:  1992-08

5.  Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat.

Authors:  S Li; X Yan; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

6.  Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells.

Authors:  M Di Monaco; A Pizzini; V Gatto; L Leonardi; M Gallo; E Brignardello; G Boccuzzi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.